NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder characterized by extreme hypertriglyceridemia and a high risk of recurrent acute pancreatitis.
S6E2: From Research to Reality: Advancing FCS Therapy
Listen to Dr. Jones speak with Shannon Christen about FCS research and therapies and recent developments.
The Lipid Panel – Hypertriglyceridemia in Patients with T2DM
Practical Pearls – PALISADE Trial and Plozasiran, a new triglyceride-lowering drug
S6E1: The Role of Nutrition-Related Clinical Trials in Informing Dietary Recommendations for Health and Treatment of Diseases
Listen to Dr. Jones discuss the topic of nutrition-related clinical trials with Dr. Kris-Etherton and Dr. Petersen from the recent JCL publication.
The Lipid Panel – Diabetes and ASCVD Risk
Ionis Receives FDA Approval for TRYNGOLZA (Olezarsen) for Adults with FCS
On December 19, 2024, Ionis Pharmaceuticals, Inc. received FDA approval for TRYNGOLZA (Olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia…
Industry Innovations | Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO
In this episode of Industry Innovations, host Dr. Peter Jones is joined by Dr. Guy Mintz to explore an exciting advancement in cardiovascular care: LODOCO, a…
